Literature DB >> 12164795

Membranes for therapeutic apheresis.

Shuhei Nakaji1, Tsuneatsu Yamamoto.   

Abstract

Kuraray has developed many kinds of apheresis devices, such as plasma separators, plasma fractionators, and apheresis monitors. In this article, apheresis membranes, especially double filtration plasmapheresis (DFPP) and plasma fractionators used in DFPP are introduced. DFPP is both clinically and cost effective apheresis therapy, and it has been used widely for the treatment of many kinds of diseases. Several types of plasma separators with various pore sizes are available. It is important to select the proper plasma separator with suitable pore size, determined by the size of the pathogenic substances to be removed. The Evaflux 5A ethylene-vinyl alcohol copolymer plasma fractionator efficiently separates low-density lipoprotein from high-density lipoprotein. DFPP with the Evaflux 5A is effective for the treatment of familiar hyperlipidemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12164795     DOI: 10.1046/j.1526-0968.2002.00442.x

Source DB:  PubMed          Journal:  Ther Apher        ISSN: 1091-6660


  3 in total

1.  Double-filtration plasmapheresis for resolution of corticosteroid resistant adult onset Still's disease.

Authors:  Takashi Kato; Tatsuo Kobayashi; Hiroshi Nishino; Yuji Hidaka
Journal:  Clin Rheumatol       Date:  2006-03-28       Impact factor: 2.980

2.  Application of biological age assessment of Chinese population in potential anti-ageing technology.

Authors:  Xufeng Li; Jiren Zhang; Chen Sun; Yuanyuan Zhang; Rui Cai; Shilin Fu; Jingfen Zheng; Dehai Huang
Journal:  Immun Ageing       Date:  2018-12-18       Impact factor: 6.400

3.  Difficult Journey to Find the Best Treatment for Homozygous Familial Hypercholesterolemia: Case Report.

Authors:  Ming-Jun Xu; Jian-Ping Chu; Wen-Ling Fei; Juan Wang; Yan-Min Zhang; Yi Wang
Journal:  Int Med Case Rep J       Date:  2022-03-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.